Abstract
The age-adjusted estimated incidence rate of testicular cancer is low (under 2/ 100,000) but significant cancer in young age in Japan. The development of effective cisplatin (CDDP)-based combination chemotherapy has improved the prognosis of advanced testicular cancer patients. The present study was conducted to investigate the prognosis of advanced testicular cancer patients treated with several effective CDDP-based chemotherapy regimens.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
